World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Oct 23
WHO questions methodology of Lancet study on malaria mortality
Expressing serious doubts over the high estimates of 200,000 malaria deaths in India as reported in the latest edition of The Lancet, the World Health Organisation (WHO) on Thursday questioned the methodology adopted by the authors of the study.

The Lancet uses verbal autopsy method which is suitable only for diseases with distinctive symptoms and not for malaria. Malaria has symptoms similar to many other diseases, and cannot be correctly identified by the local population.

The use of verbal autopsy for malaria may result in many false positives. In this method, deaths due to fever from any cause are likely to be misinterpreted as malaria in areas with high incidence. In areas with low malaria incidence, the symptoms are difficult to distinguish, and would result in overestimates of malaria deaths, a statement issued by the WHO here said.

Independent studies

It said the organisation welcomed independent studies for estimating malaria deaths, provided the method used was appropriate. The limitations of verbal autopsy, and the implausibly high incidence rates implied by the malaria mortality estimates, indicate that the findings of the study cannot be accepted without further validation.

Malaria is endemic in many States of India. Maximum cases are reported from the North Eastern States, Orissa, Jharkhand, Chhattisgarh and a few districts of Maharashtra, Madhya Pradesh and Andhra Pradesh. Approximately 50 per cent of malaria cases reported in the country are due to Plasmodium Falciparum (a type of malaria which causes death), the statement said.

The WHO estimated 10,000 (deaths) - 21,000 malaria deaths in India in 2006 - based on the rate of three deaths per 1000 estimated falciparum cases. Estimates of falciparum cases are made by multiplying total estimated malaria cases by reported falciparum percentage. These estimates make necessary adjustments for under-reporting of malaria data in the countries.

This methodology was universal, it said, admitting that the present malaria estimation procedures had limitations.

Concerns raised

Pointing out that the same authors, in a study in 2005, had warned against the use of verbal autopsy for obtaining malaria death estimates, the statement said, "Given these methodological concerns raised already in the early stages of this new study, the WHO had proactively supported a project to validate the methodology of verbal autopsy used in the study. The findings of the project reconfirmed that verbal autopsy method overestimates malaria deaths.

The method was found to estimate deaths correctly only in 8 per cent fatalities."

Setbacks of the method

"This new study published in The Lancet also has bias, as deaths during 2001-03 have been assessed much later in 2005-06. Any adult member of the family or even a neighbour was interviewed during the verbal autopsy, and it is not clear how well the interviewee was familiar with the case during the period of illness prior to the death," the WHO said.

The limitations of the new study were also exposed when estimates were examined for particular States. The proposed estimate of malaria mortality in Orissa suggests, implausibly, that there are 17-50 million falciparum malaria cases annually in a population of 40 million.

Oct 22
79 more dengue cases in Delhi
A total of 79 more cases of dengue were confirmed in Delhi on Thursday, taking to 4,826 the number of those infected with the vector-borne disease, officials said. A total of eight people have died due to the disease in Delhi this year.

Areas like Rohini and Civil Lines continue to be the worst-affected with around 1,200 combined cases reported from there.

Oct 22
If you're over 45 and going weak at the knees, act now
If you are over 45 and find yourself going weak at the knees, don't think that Cupid is shooting its arrow at you! The bones of your legs may have fallen victim to osteoporosis, an unhealthy condition in which the bones become porous.

Osteoporosis is characterised by a decrease in bone density and bone mass which makes the bones of the body fragile and weak.

Nearly 20% of the women and 12 percent of the men aged 50 or above in India suffer from osteoporosis but the disorder remains largely under-diagnosed and undertreated. The prevalence of osteoporosis is even more widespread in rural and semi-urban areas.

Weakening of the bones leads to unexpected fractures that can occur anywhere in the body. Nowadays, more than 80 percent of all spinal fractures are caused by osteoporosis, say experts.

Another area of the body commonly affected by osteoporosis is the hip bone.

Apart from the pain and immobility they cause, the long-term consequences of fractures caused by osteoporosis include debilitating pain, spinal deformity, functional, and psychosocial impairments, poor pulmonary function and risk of fresh fractures.

The contemporary view in medicine is that osteoporosis is something of a lifestyle disease, too, as poor food habits and consumption of alcohol aggravate the condition. With the World Osteoporosis Day falling on October 20, experts have reiterated the need to raise awareness about how osteoporosis can be prevented.

Dr Bharat Dave, a spine surgeon and member of the association of spine surgeons of India (ASSI), said that most major osteoporotic fractures occur in the spine, wrist or the hip bones.
"During puberty and adolescence, the skeleton absorbs calcium avidly and builds up its reserves," Dave said. "The amount of calcium converted into bone is largely dependent on calcium and vitamin D nutrition, as well as exercise."

Bones continue to grow in strength till the age of 30. But from the mid-thirties, there is a gradual bone loss that continues throughout life.

Osteoporosis is not completely curable; hence its prevention is as important as its treatment. The most important prevention measures include quitting smoking, curtailing excessive intake of alcohol, exercising regularly, and consuming a balanced diet with adequate calcium and vitamin D content, Dave said.

Oct 20
Low testosterone 'may raise risk of early death'
A new research has linked low testosterone levels to a heightened risk of premature death from heart disease and all causes. The finding refutes received wisdom that the hormone is a risk factor for cardiovascular disease.

Researchers base their findings on 930 men, all of whom had coronary artery heart disease, and had been referred to a specialist heart centre between 2000 and 2002. Their heart health was then tracked for around 7 years.

On referral, low testosterone was relatively common. One in four of the men was classified as having low testosterone, using measurements of either bio-available testosterone (bio-T) - available for tissues to use - of under 2.6 mmol/l or total testosterone (TT) of under 8.1 mmol/l.

These measures indicate clinically defined testosterone deficiency, referred to as hypogonadism, as opposed to a tailing off in levels of the hormone as a result of ageing.

During the monitoring period almost twice as many men with low testosterone died as did those with normal levels. One in five (41) of those with low testosterone died, compared with one in eight (12pc) of those with normal levels.

The only factors that influenced this risk were heart failure (left ventricular dysfunction), treatment with aspirin or a high blood pressure drug (beta blocker) and low bio-T levels.

A low bio-T level was an independent risk factor for premature death from all causes and from heart disease, after taking account of other influential factors, such as age, other underlying health problems, smoking and weight.

Borderline levels of low total testosterone (15.1mmol/l) also increased the risk of an early death.

While high doses of testosterone found in anabolic steroids are harmful to health, the evidence suggests that low, rather than high, levels of the hormone, are associated with obesity, risky blood fats, and insulin resistance, all of which are risk factors for diabetes and heart disease, say the authors.

Men at high risk of these diseases may stand most to gain from testosterone replacement, they suggest.

The study has been published online in Heart.

Oct 20
Osteoporosis is a lifestyle disorder
The number of people affected by osteoporosis in India is higher than those in Western countries,doctors in the city said on the eve of the World Osteoporosis Day.

Osteoporosis, a disease of the bones that leads to an increased risk of fracture, was becoming a lifestyle disease, they said.

Dr Mahesh Bijjawara, spine surgeon at Jain Hospital, said, "The incidence of osteoporotic hip fractures is in the ratio of one woman to one man in India, while in the Western world, it is three women to one man. Also in the West, the peak incidence of osteoporosis occurs only when the person is about 70-80 years of age, while in India it afflicts them even at 50." He also underlined the importance of adequate calcium intake during the growing years to prevent the disease.

There was a gradual progressive bone loss from the mid-30s, which continued throughout life and was accelerated during menopause in women, he added.

Treatment options available for prevention of post-menopausal osteoporosis include estrogens and progesterone hormone replacement therapy, amongst others.

Leading a healthy lifestyle, quitting smoking, curtailing alcohol consumption, regular exercise and a balanced diet will help in keeping the disease at bay.

Oct 19
India's 1st cell-cultured swine flu vaccine launched
Finally, India gets its first indigenously developed cell culture vaccine to fight the lethal swine flu strain.

The single-dose vaccine developed by Bharat Biotech's scientists at the Genome Valley facility in Hyderabad was launched on Monday, under the brand name HNVAC to help the country fight the spread of the disease.

At the launch, Bharat Biotech's chairman and managing director, Dr Krishna Ella stated, "We are pleased to announce the launch of HNVAC to help prevent the spread of H1N1 pandemic influenza, which can spread rapidly with a high rate of disease and death. Bharat Biotech is proud to develop and offer this vaccine with the best USFDA recommended cell culture technology for Indian consumers."

A little about HNVAC
HNVAC developed for the H1N1 pandemic strain, is the only vaccine manufactured from the developing world which uses mammalian cell culture technology instead of eggs.

This is a highly sterile, safe and controlled manufacturing process.

This places the flu vaccine ahead of many international as well as national pharmaceutical companies where eggs are still used for manufacturing.

Egg based vaccines are discouraged since they may be accompanied with adverse reaction from egg based protein, especially in children.

Krishna Ella stated, "The key benefit of our cell culture vaccine is its potential to scale up and produce large quantities quickly as required, it also has a much more sterile and faster production cycle, without the external dependence on eggs and thus enabling quicker response times in the event of a pandemic."

Safety and efficacy assessed
The safety and efficacy of HNVAC was tested extensively in one of the largest phase I, II and III clinical trials for flu vaccines in the country.

The trials proved that the vaccine is hundred percent safe, effective, well tolerated and affordable.

The vaccine was developed with approved strains from World Health Organization (WHO) and centre for Disease Control (CDC) Atlanta.

HNVAC has been approved by the Drug Controller of India (DCGI) and can be safely administered to any individual above three years.

The vaccine will be available for commercially use both through government and private agencies.

H1N1 still a threat
H1N1 is a highly contagious respiratory disease caused by swine influenza virus.

The deadly disease is characterized by tiredness, fever, sore throat, runny nose, muscle pains, headache, coughing, weakness, vomiting, loss of appetite and general discomfort.

WHO declared on 10 August 2010 that the pandemic was officially over, hence H1N1 is now in the post-pandemic period.

Medical experts caution the public not to ignore H1N1 flu because it will be one of the main viruses circulating this winter.

Krishna Ella stated, "While there's certainly widespread and growing concern around H1N1, there are number of people, who did not get a flu shot last year.

"Our goal right now is to make the flu vaccine easily accessible and at affordable cost to high risk groups."

Oct 19
Vitamin A pill could protect the sight of millions
A drug based on vitamin A could prevent millions from going blind as they get older, say researchers. The treatment was able to stop the most common cause of blindness in old age during trials. Researchers behind the drug, fenretinide, found it halted the advance of age-related
macular degeneration, for which there is currently no cure.

They targeted the most prevalent form of the condition, known as 'dry' AMD, which is caused by the deterioration and death of cells in the macula - the part of the retina used to see straight ahead.

The disease robs sufferers of their sight by creating a blackspot in the centre of their vision, reports the Daily Mail.

It can make it impossible to carry out everyday tasks such as reading, driving and watching television.

While the less common 'wet' form can be treated, nothing can be done to help the bulk of patients.

The US research studied fenretinide, which is derived from vitamin A, the vitamin found in carrots, and which was originally designed to tackle arthritis.

Almost 250 men and women with dry AMD took a fenretinide pill a day or a placebo.

In the highest dose, the drug halted visual deterioration after a year. This suggests that while it was unable to do anything to stop cells that were already damaged from dying, it protected healthy cells.

Although the research is still preliminary, it offers promise of a treatment for the disease.

It affects millions across the world. The number of British sufferers could more than treble to one million within 25 years as the population ages.

Jason Slakter of New York University School of Medicine said: "There are currently no effective treatments for dry AMD and the need for finding one is grave."

Oct 16
Broken homes result in disruptive children: Study
Children from broken homes are twice as likely to develop serious behavioural problems, compared to children living with their parents, a study says.

Researchers in Britain, who tracked nearly 13,500 children aged one to seven, found that living with a single parent or step-parents doubled their risk of developing emotional problems, poor behaviour and hyperactivity, reports the Daily Mail.

Separately, the study found almost a third of seven-year-olds living without either of their parents.

15 percent who lived with step-parents, and 12 percent from a single-parent family displayed serious behavioural problems, the government-funded report found.

Their emotional well-being was likely to be 'under considerable pressure', according to the Millennium Cohort Study, which is tracking children born in 2000.

Conversely, just six percent of children living with their parents developed similar behaviour.

'Living apart from one's natural father can be associated with poverty and negative outcome for the children,' said co-author Lisa Calderwood of London's Institute of Education.

Children living with working parents, or parents with higher educational qualifications, were less likely to suffer behavioural problems, the study

Oct 16
Mouse Study Sheds Light on Hearing Loss in Aging Humans
New insight into how different types of age-related hearing loss may occur could help lead to the development of drugs to preserve hearing, scientists say.

The team at the University of Minnesota Medical School looked at how two closely related genes affect hearing in mice. Mutations in these genes are associated with deafness in humans, they noted.

The study, published online Oct. 14 in PLoS Genetics, found that proteins produced by the genes play a key role in two important processes that are required to maintain hearing in mice.

"These separate maintenance pathways are likely important for maintaining auditory function during aging and may contribute to future understanding of common forms of age-related hearing loss in humans," study author Ben Perrin said in a news release from the journal's publisher.

Because animal studies frequently fail to produce beneficial results for humans, additional research is needed.

Funding for the study was supplied by the U.S. National Institutes of Health.

Oct 15
Neglected tropical diseases
A report on Neglected Tropical Diseases released by the World Health Organisation this week has outlined the breathtaking economic cost that developing countries such as India face in coping with diseases such as hookworm infection, lymphatic filariasis and visceral leishmaniasis, commonly known as kala-azar.

In the report WHO Director-General Margaret Chan underscored the linkages between such NTDs and poverty, saying, "Neglected tropical diseases have traditionally ranked low on national and international health agendas." She added that currently impaired the lives of an estimated 1 billion people, mostly in remote rural areas or urban slums and shantytowns.

According to Dr. Chan, NTDs usually caused massive but hidden and silent suffering, and frequently killed those infected, but not in numbers comparable to the deaths caused by HIV/AIDS, tuberculosis or malaria. She also noted that the presence of these debilitating illnesses also often went unnoticed by health authorities as those affected or at risk generally had "little political voice."

Speaking to The Hindu, Peter Hotez, President of the Sabin Vaccine Institute and a spokesperson for the Global Network for Neglected Tropical Diseases, corroborated the WHO's assessment of the current state of NTDs, including the possibility that these diseases frustrated the achievement of health in the Millennium Development Goals.

Touching on the scene in India in particular Dr. Hotez said, "India still remains the epicentre for NTDs," noting for example that there were currently close to 70 million cases of hookworm infection. This was "of great concern" because childhood infection reduces future wage earning by 40 per cent, according to a 2007 study mentioned in the report.

Given the disproportionately large impact of such NTDs on the lower strata of the population, the vaccines for these NTDs are known as "antipoverty vaccines," Dr. Hotez explained. He said that the reason such diseases received less official attention was because they "do not kill, but cause high morbidity and economic loss, and this is killing India."

Citing the case of lymphatic filariasis - also know elephantiasis - Dr. Hotez quoted another study which indicated that India faced "almost a billion dollars loss per year, economically," from the disease.

While the WHO report said that India had undertaken national efforts to reduce the impact of leishmaniasis and filariasis, Dr. Hotez warned that "for hookworm infection it is too widespread to even consider elimination at this point." He noted that for this disease there was a need for a vaccine and the Sabin Institute was working on such a vaccine,

In the international arena, Dr. Hotez said, the contributions of European governments and developing country governments did not come anywhere near the major efforts of the U.S. to control NTDs worldwide, with the United Kingdom's Department for International Development being a notable exception. "Other countries should be doing more to help control NTDs at the global level," he said.

Browse Archive